Deep Sclerectomy.
Roy S, Mermoud A.
Dev Ophthalmol. 2017;59:36-42. doi: 10.1159/000458484. Epub 2017 Apr 25.
Deep sclerectomy.
Roy S, Mermoud A.
Dev Ophthalmol. 2012;50:29-36. doi: 10.1159/000334772. Epub 2012 Apr 17.
Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma.
Kozobolis V, Kalogianni E, Sideroudi H.
Eur J Ophthalmol. 2020 Mar;30(2):264-268. doi: 10.1177/1120672119827768. Epub 2019 Feb 17.
Deep sclerectomy-trabeculectomy with mitomycin C in treating glaucoma: postoperative long-term results.
Chean CS, Jiang L, Pati Arambage GKN, Ranjit P.
Int J Ophthalmol. 2022 Dec 18;15(12):1951-1959. doi: 10.18240/ijo.2022.12.09. eCollection 2022.
Deep Sclerectomy With Intrascleral Versus Suprachoroidal Collagen Implant: A Randomized Control Trial.
Mitwally R, Aref A, Shaarawy T.
J Glaucoma. 2021 Feb 1;30(2):124-128. doi: 10.1097/IJG.0000000000001703.
Deep sclerectomy after DSAEK: A cautionary tale.
Salam A.
BMJ Case Rep. 2021 Jun 15;14(6):e237541. doi: 10.1136/bcr-2020-237541.
Sutureless versus conventional deep sclerectomy for management of open angle glaucoma.
Kotb MS, El Gharbawy SA, Abdelrahman AM, Makled HS.
Graefes Arch Clin Exp Ophthalmol. 2023 Apr;261(4):1083-1090. doi: 10.1007/s00417-022-05910-4. Epub 2022 Nov 26.
Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes.
Dwivedi R, Somerville T, Cheeseman R, Rogers C, Batterbury M, Choudhary A.
Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1965-1974. doi: 10.1007/s00417-021-05144-w. Epub 2021 Mar 8.
Outcomes of Deep Sclerectomy for Glaucoma Secondary to Sturge-Weber Syndrome.
Almobarak FA, Alobaidan AS, Alobrah MA.
J Clin Med. 2023 Jan 8;12(2):516. doi: 10.3390/jcm12020516.
Deep sclerectomy versus trabeculectomy in eyes with penetrating keratoplasty.
Loriaut P, Nordmann JP, Laroche L, Borderie VM.
Cornea. 2015 Apr;34(4):375-80. doi: 10.1097/ICO.0000000000000367.
